22 / 25
6
t h
A n n u a l E u r o p e a n C o n f e r e n c e o n
Gastroenterology
Euro Gastro 2018
J u n e 1 9 - 2 0 , 2 0 1 8
P a r i s , F r a n c e
Page 48
Journal of Clinical Gastroenterology and Hepatology
ISSN 2575-7733
Biography
Waleed Gado has completed his master’s degree in Surgery
in 2008, PhD in 2014 from Mansoura University, Egypt. He is
currently an Assistant Professor of Endocrine and Bariatric/
Metabolic Surgery. He is also a Consultant Surgeon in Egypt and
Arab Gulf countries. His interest and research is mainly focused
on minimally invasive approaches for endocrinal diseases and
bariatric surgeries.
waleedgado79@gmail.comEfficacy of MGB in diabetic patients with body mass index <35 kg/m
2
Waleed Gado
1
and T Mahdy
1,2
1
Mansoura University, Egypt
2
Al Qassimi Hospital, UAE
Waleed Gado et al., J Clin Gastroenterol Hepatol 2018, Volume: 2
DOI: 10.21767/2575-7733-C1-002
Background:
A lot of reports have shown that patients with body mass index
(BMI)>35kg/m
2
who underwent metabolic surgery experienced resolution of type 2
diabetes (T2DM). One of those bariatric surgery proved to be safe, effective, reliable
and reversible is Mini-gastric bypass (MGB). Little studies addressed the efficacy of
MGB on the resolution of T2DM in patients with BMI< 35 kg/m
2
.
Objectives:
We aimed to evaluate the efficacy of MGB on resolution of T2DM in patients
with BMI< 35 kg/m
2
.
Methods:
From March 2011 to May 2015; 135 patients with T2DM and BMI<35 kg/m2
underwent MGB were enrolled in this study. The changes in fasting blood sugar (FBS),
glycosylated haemoglobin (HbA1c), alanine transaminase (ALT), C-peptide, total body
weight and the use of oral hypoglycemic agents and insulin at the end of one year were
studied.
Results:
108 patients (80 %) showed resolution, 25 patients (18.5 %) showed remission
and only two patients (1.5 %) failed to respond after surgery as shown in fig1. There
was statistically significant changes in BMI, FBS, and HbA1c (fig 2) one year post
operatively with p-value<0.05. The duration of T2DM, preoperative treatment, ALT, and
C-peptide seem to be of paramount importance as prognostic factors for resolution of
T2DM after surgery.
Conclusion:
Our study showed that MGB is associated with a high rate of resolution of
T2DM at 12 months after surgery in diabetic patients.
Efficacy of MGB on T2DM
Gastrografin meal follow
through following MGB
Changes in BMI, FBS and HbA1c after one year of surgery: BMI, body
mass index; FBS, fasting blood sugar; HbA1c, glycosylated haemoglobin